| Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial SMM Verstappen, MJ McCoy, C Roberts, NE Dale, AB Hassell, ... Annals of the rheumatic diseases 69 (3), 503-509, 2010 | 147* | 2010 |
| Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial SMM Verstappen, MJ McCoy, C Roberts, NE Dale, AB Hassell, ... Annals of the rheumatic diseases 69 (3), 503-509, 2010 | 130 | 2010 |
| A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters AK Nowak, RJ Francis, MJ Phillips, MJ Millward, AA van der Schaaf, ... Clinical Cancer Research 16 (8), 2409-2417, 2010 | 129 | 2010 |
| A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma AK Nowak, AM Cook, AM McDonnell, MJ Millward, J Creaney, RJ Francis, ... Annals of Oncology 26 (12), 2483-2490, 2015 | 93 | 2015 |
| Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer MJ McCoy, C Hemmings, TJ Miller, SJ Austin, MK Bulsara, N Zeps, ... British journal of cancer 113 (12), 1677-1686, 2015 | 77 | 2015 |
| Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies MJ McCoy, RA Lake, RG Van Der Most, IM Dick, AK Nowak British journal of cancer 107 (7), 1107-1115, 2012 | 67 | 2012 |
| The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis MJ Harrison, LM Davies, NJ Bansback, MJ McCoy, SMM Verstappen, ... Quality of Life Research 18, 1195-1205, 2009 | 67 | 2009 |
| Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection JR Kerr, M McCoy, B Burke, DL Mattey, V Pravica, IV Hutchinson Journal of clinical pathology 56 (10), 725-727, 2003 | 63 | 2003 |
| Association between novel GM-CSF gene polymorphisms and the frequency and severity of atopic dermatitis H Rafatpanah, E Bennett, V Pravica, MJ McCoy, TJ David, IV Hutchinson, ... Journal of allergy and clinical immunology 112 (3), 593-598, 2003 | 51 | 2003 |
| The genetic predisposition to produce high levels of TGF-β1 impacts on the severity of eclampsia/pre-eclampsia GA Stanczuk, MJ Mccoy, IV Hutchinson, EN Sibanda Acta obstetricia et gynecologica Scandinavica 86 (8), 903-908, 2007 | 44 | 2007 |
| The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3 TJ Miller, MJ McCoy, C Hemmings, MK Bulsara, B Iacopetta, CF Platell Pathology 49 (7), 721-730, 2017 | 41 | 2017 |
| Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response MJ McCoy, C Hemmings, CC Anyaegbu, SJ Austin, TF Lee-Pullen, ... Oncotarget 8 (12), 19803, 2017 | 38 | 2017 |
| Why do patients with inflammatory arthritis often score states “worse than death” on the EQ‐5D? An investigation of the EQ‐5D classification system MJ Harrison, LM Davies, NJ Bansback, MJ McCoy, TM Farragher, ... Value in Health 12 (6), 1026-1034, 2009 | 33 | 2009 |
| PD‐L1+ dendritic cells in the tumor microenvironment correlate with good prognosis and CD8+ T cell infiltration in colon cancer TJ Miller, CC Anyaegbu, TF Lee‐Pullen, LJ Spalding, CF Platell, ... Cancer Science 112 (3), 1173-1183, 2021 | 31 | 2021 |
| Peripheral CD8+ T cell proliferation is prognostic for patients with advanced thoracic malignancies MJ McCoy, AK Nowak, RG van der Most, IM Dick, RA Lake Cancer Immunology, Immunotherapy 62, 529-539, 2013 | 29 | 2013 |
| Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression? MJ McCoy, C Hemmings, S Hillery, C Penter, MK Bulsara, N Zeps, ... ANZ journal of surgery 87 (12), E233-E239, 2017 | 24 | 2017 |
| Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma MJ McCoy, AK Nowak, RA Lake Tissue Antigens 74 (1), 1-10, 2009 | 22 | 2009 |
| Expression of PD‑L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasion TJ Miller, MJ Mccoy, C Hemmings, B Iacopetta, CF Platell Oncology letters 16 (5), 5761-5768, 2018 | 14 | 2018 |
| Objective analysis of cancer stem cell marker expression using immunohistochemistry TJ Miller, MJ McCoy, C Hemmings, MK Bulsara, B Iacopetta, CF Platell Pathology 49 (1), 24-29, 2017 | 13 | 2017 |
| Immunohistochemical detection of PD-L1 for research studies: which antibody and what protocol? CC Anyaegbu, K Garrett, C Hemmings, TF Lee-Pullen, MJ McCoy Pathology 49 (4), 427-430, 2017 | 8 | 2017 |
